Search

You searched for "Head and Neck"

173 results found
Dysphagia journal cover image.

Predicting swallowing outcomes post radiotherapy for head and neck cancer

7 January 2021 | | ENTA - Laryngology / Swallowing / Voice | Cancer, Deglutition, Deglutition disorders, Displacement, Dysphagia, Radiation, Timing
A videofluroscopic swallow study (VFSS), also known as modified barium swallow (MBS) offers a dynamic view of swallow biomechanics and associated swallowing physiology. The authors of this paper investigated whether quantitative timing and displacement measures of key structures involved in...
American Journal of Otolaryngology cover image.

Prophylactic gastrostomy tubes in advance of chemoradiotherapy for advanced head and neck malignancies – are they worthwhile?

2 September 2022 | | ENTA - Head & Neck | Chemoradiation, Head and neck cancer, Prophylactic percutaneous endoscopic gastrostomy, Tube dependence, Weight loss
It is well recognised that radical chemoradiotherapy (CRT) for head and neck cancers can significantly affect swallowing, especially if radiotherapy is delivered to the hypopharynx and/or both sides of the neck. As such, prophylactic gastrostomy tubes are often advocated in...
Journal of Laryngology & Otology cover image.

Effects of coronavirus pandemic on presentation of head and neck cancer patients

10 March 2023 | | ENTA - Head & Neck
The COVID-19 pandemic caused unprecedented disruption of NHS services. This was compounded by patients’ reluctance to attend hospitals at that time. How this affected the presentation of patients with head and neck cancer is the subject of this study. Head...
The Laryngoscope journal cover image.

Pre-habilitation in head and neck cancer – a literature review to guide best practice

4 March 2024 | | ENTA - Head & Neck
Curative treatment of head and neck cancer (HNC) often requires surgery; however, outcomes are impacted by the complexity of the surgery and the patient population. Increasingly ‘Enhanced Recovery After Surgery’ (ERAS) protocols are being used to maximise patient outcomes and...
Laryngology & Otology journal cover image.

A safe management pathway for low-risk head and neck cancer suspected referrals

3 September 2024 | | ENTA - Head & Neck
Head and neck cancer is the eighth most common malignancy and numbers are increasing. This has led to increasing number of suspected cancer referrals which, with imposition of the 28-day Faster Diagnosis Standard implemented in 2020, has further burdened the...

Why and how I enjoy the history of Otorhinolaryngology, Head and Neck Surgery (OHNS)

1 September 2015 | | ENTA - ENT
In the first article of this History of ENT edition, Albert Mudry explains why history is so intrinsically relevant to the practice of medicine and tells us how to use history as a foundation for the discovery of new ideas,...

Robotic head and neck surgery: current state of the art and future innovations

1 March 2016 | | ENTA - ENT, ENTA - Head & Neck
Technology and innovation has provided modern head and neck surgeons with successive generations of robotic surgical systems, fibre-optic lasers, and novel tools which have ushered in a new era of minimally invasive surgery for tumours of the pharynx and larynx....

Progress of head and neck surgery in China over the last 20 years

1 March 2017 | | ENTA - ENT, ENTA - Head & Neck
Although China was late to establish head and neck surgery in comparison to other areas of oncological surgery, with the persistent hard work of head and neck surgeons nationally, it has progressed significantly during the last two decades. Yueying Ma...

Changing perceptions in head and neck cancer management caused by quality of life issues

1 September 2010 | | ENTA - Head & Neck, ENTA - ENT, ENTA - Laryngology / Swallowing / Voice
Sir Felix Semon was an outstanding clinician and exceptional laryngologist. The money raised by donations from his colleagues on his retirement in 1909 was used to establish the London University’s Semon Lecture. Semon’s Obituary in the BMJ, reads: “In Semon's...

Treatment regret in head and neck cancer – trading function for survival

2 July 2025 | | ENTA - Head & Neck
Treatment for H&N cancer can be extremely tough for patients. How do we explain the likely impact as they try to make decisions? And what happens when they regret their choice? Treatment regret is a form of decision regret, involving...

Exploring the role of oral microbiota in head and neck squamous cell carcinoma

4 September 2025 | | ENTA - Head & Neck
Oral microbiota, especially Fusobacterium nucleatum, may improve survival and guide personalised treatment in head and neck squamous cell carcinoma. Head and neck squamous cell carcinoma (HNSCC) is a devastating disease with a low five-year survival rate that has shown little...

Head and neck cancer deaths to cost $535 billion by 2030

3 March 2021 | | ENTA - ENT, ENTA - Head & Neck
More than 500,000 people across the globe will die this year from head and neck cancer, which is the sixth most common cancer in the world and comprises malignancies of the nose, mouth, throat, larynx, and neck. Assuming current trends...